Literature DB >> 16544115

Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.

Stefan Schrader1, Thilo Wedel, Ralf Moll, Gerd Geerling.   

Abstract

BACKGROUND: The treatment of persistent epithelial defects (PED) with autologous serum eye drops is often combined with conventional medication such as artificial tears and topical antibiotics, but until now no report exists on the use of a bandage contact lens (BCL) in combination with autologous serum eye drops in the treatment of PEDs. We report six eyes (five patients) which were all treated with autologous serum eye drops in combination with an FDA group IV hydrogel contact lens.
METHODS: Five patients aged 36-88 years, were suffering from six PEDs for 73.5+/-46.9 days due to rheumatoid sterile corneal ulcer (n=1), neurotrophic keratopathy (n=3) or partial limbal stem cell deficiency (n=1). All patients had been unsuccessfully treated with conventional therapy before. Three of them had already had an amniotic membrane transplantation and two had undergone a keratoplasty; however, the epithelial defect persisted or recurred. In all cases, an FDA group IV hydrogel contact lens (Biomedics 55, ocufilcon D, 55% water content) was fitted and serum eye drops applied 8 times a day.
RESULTS: The PED healed in five of six eyes after a treatment period of 14.2+/-8.9 days. In one eye the PED became smaller, but it took 90 days until the lesion healed completely. In three eyes (two patients) white deposits appeared on the surface of the BCL during the treatment after 12.3+/-5.1 days. Because no signs of inflammation were observed and since the epithelial defect improved, a new identical lens was applied and the medication continued unaltered. The surface of contaminated and non-contaminated BCLs were analyzed by scanning electron microscopy and SDS gel-electrophoresis. The scanning electron microscopic examination presented a coating of amorphous material with a wrinkled appearance and many corpuscular deposits. There was no indication of bacterial colonisation. The SDS gel-electrophoresis showed a small band at 65 kDa, probably albumin.
CONCLUSION: These findings suggest that the combination of a therapeutic contact lens and serum eye drops can be successfully used in the treatment of persistent epithelial defects. Deposition of albumin may occur on the surface of the contact lenses, which, in the small group presented here, caused no unwanted effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544115     DOI: 10.1007/s00417-006-0257-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  20 in total

1.  Recurrent erosion of the cornea.

Authors:  N Brown; A Bron
Journal:  Br J Ophthalmol       Date:  1976-02       Impact factor: 4.638

2.  An optimised protocol for the production of autologous serum eyedrops.

Authors:  L Liu; D Hartwig; S Harloff; P Herminghaus; T Wedel; G Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The nature of "spots" on soft lenses.

Authors:  D J Doughman; E Mobilia; D Drago; V Havener; M Gavin
Journal:  Ann Ophthalmol       Date:  1975-03

5.  Treatment of dry eye by autologous serum application in Sjögren's syndrome.

Authors:  K Tsubota; E Goto; H Fujita; M Ono; H Inoue; I Saito; S Shimmura
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

6.  Treatment of persistent corneal epithelial defect by autologous serum application.

Authors:  K Tsubota; E Goto; S Shimmura; J Shimazaki
Journal:  Ophthalmology       Date:  1999-10       Impact factor: 12.079

7.  Visual decrement with deposit accumulation of HEMA contact lenses.

Authors:  K W Gellatly; N A Brennan; N Efron
Journal:  Am J Optom Physiol Opt       Date:  1988-12

Review 8.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

9.  The natural history and management of recurrent corneal erosion: a prospective randomised trial.

Authors:  P G Hykin; A E Foss; C Pavesio; J K Dart
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

10.  Identification of proteins in contact lens surface deposits by immunofluorescence microscopy.

Authors:  O G Gudmundsson; D F Woodward; S A Fowler; M R Allansmith
Journal:  Arch Ophthalmol       Date:  1985-02
View more
  23 in total

1.  Pathophysiology of Corneal Scarring in Persistent Epithelial Defects After PRK and Other Corneal Injuries.

Authors:  Steven E Wilson; Carla S Medeiros; Marcony R Santhiago
Journal:  J Refract Surg       Date:  2018-01-01       Impact factor: 3.573

Review 2.  [Phototherapeutic keratectomy. Undesirable effects, complications, and preventive strategies].

Authors:  G Geerling; W Sekundo
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

3.  [On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)].

Authors:  K Kasper; L Godenschweger; D Hartwig; J D Unterlauft; B Seitz; G Geerling
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

4.  The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on neurobiology.

Authors:  Fiona Stapleton; Carl Marfurt; Blanka Golebiowski; Mark Rosenblatt; David Bereiter; Carolyn Begley; Darlene Dartt; Juana Gallar; Carlos Belmonte; Pedram Hamrah; Mark Willcox
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-18       Impact factor: 4.799

Review 5.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

6.  Management strategies for persistent epithelial defects of the cornea.

Authors:  Lee R Katzman; Bennie H Jeng
Journal:  Saudi J Ophthalmol       Date:  2014-07-02

7.  Fingerprick autologous blood: a novel treatment for dry eye syndrome.

Authors:  J Than; S Balal; J Wawrzynski; N Nesaratnam; G M Saleh; J Moore; A Patel; S Shah; B Sharma; B Kumar; J Smith; A Sharma
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

8.  Application of autologous serum eye drops after pterygium surgery: a prospective study.

Authors:  Sabahattin Sul; Safak Korkmaz; Goksu Alacamli; Pelin Ozyol; Erhan Ozyol
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-18       Impact factor: 3.117

Review 9.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

10.  [Manufacture of autologous serum eye drops for out-patient therapy : cooperation between ophthalmic clinic and transfusion medicine department].

Authors:  T Dietrich; V Weisbach; B Seitz; C Jacobi; F E Kruse; R Eckstein; C Cursiefen
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.